Skeletal muscle, the powerhouse of movement and a cornerstone of physical vitality, is unfortunately prone to a gradual decline that often commences early in the aging process. This deterioration can manifest as a significant loss of strength, an increase in fibrotic tissue or scarring within the muscle, an accumulation of fat, and a notable reduction in fast-twitch muscle fibers – the very fibers crucial for generating rapid, explosive power. Understanding and counteracting these age-related changes is a critical area of biomedical research, with profound implications for maintaining quality of life and independence in later years.
In a significant stride toward this goal, researchers at Kyushu University’s Faculty of Agriculture, led by Professor Ryuichi Tatsumi, have pinpointed a molecule with the potential to both protect and amplify a vital signaling pathway involved in muscle repair. The groundbreaking findings of their investigation were formally published on July 24, 2026, in the esteemed scientific journal Scientific Reports. This discovery offers a promising new avenue for therapeutic intervention against age-related sarcopenia and other muscle-wasting conditions.
The Body’s Intricate Muscle Repair Mechanism
At the heart of this research lies the hepatocyte growth factor (HGF), a pivotal protein that plays a crucial role in initiating and orchestrating the repair of skeletal muscle tissue. Under normal physiological conditions, HGF is maintained in an inactive state, intricately integrated within the extracellular matrix – the structural scaffolding that surrounds and supports muscle fibers. This quiescent state ensures that repair processes are only triggered when necessary, preventing premature or unwarranted cellular activity.
The body’s sophisticated system for muscle regeneration is activated when muscle tissue sustains damage, whether from physical injury, strenuous exercise, or other forms of mechanical stress. Upon such stimuli, HGF is released from its bound state. Once liberated, HGF embarks on a critical journey to engage with its specific receptor, known as c-MET, which is predominantly expressed on the surface of satellite cells. These satellite cells are the resident stem cells of skeletal muscle, acting as a vital reserve population responsible for maintaining muscle homeostasis and orchestrating repair and regeneration.
The binding of HGF to its c-MET receptor acts as a potent signal, rousing the satellite cells from their dormant state. This activation is the initial cascade that prompts these stem cells to proliferate, differentiate into mature muscle cells (myocytes), and ultimately contribute to the rebuilding and repair of damaged muscle fibers. This intricate signaling pathway is fundamental to preserving muscle mass and function throughout life.
Aging’s Toll on Muscle Repair Pathways
However, the efficacy of this crucial repair system can be compromised by the inexorable process of aging. Previous investigations by Professor Tatsumi’s research group had already shed light on a significant vulnerability within the HGF pathway. Their prior work, published in Cellular and Molecular Life Sciences (doi.org/10.1111/acel.14041), revealed that HGF is susceptible to a specific chemical modification known as nitration.
Nitration involves the addition of a nitro group (NO2) to specific amino acid residues within the protein structure. In the case of HGF, this detrimental modification was found to occur at two key tyrosine residues: Y198 and Y250. Critically, these nitrated sites are located within the very region of the HGF molecule that is responsible for its high-affinity binding to the c-MET receptor.
Following nitration, the structural integrity of HGF is altered, severely impairing its ability to dock effectively with its intended receptor. The researchers aptly describe this functional loss as akin to a "rusted key" that can no longer fit its corresponding lock. This impaired binding capacity is hypothesized to be a significant underlying factor contributing to the observed muscle wasting and diminished regenerative capacity that often characterize older adults.
"HGF is not necessarily absent or depleted as we age," Professor Tatsumi elaborated in a statement accompanying the recent publication. "Instead, its functional efficacy can be compromised by chemical alterations that occur after its synthesis. This observation led us to hypothesize whether a compound possessing potent antioxidant capabilities could serve to protect HGF. Such a compound might achieve this either by preventing the nitration process itself or by mitigating the functional deficits that arise from this modification."
Exploring Sulfur-Based Antioxidants for HGF Protection
Driven by this hypothesis, the research team embarked on an experimental exploration of two compounds renowned for their powerful antioxidant properties: glutathione trisulfide (GSSSG) and lipoic acid trisulfide (LASSS). Both of these molecules belong to the trisulfide class, characterized by a chain of three sulfur atoms linked together. Trisulfides have garnered increasing attention in pharmaceutical research due to their unique sulfur chemistry and their active participation in crucial redox reactions within biological systems.
Initial laboratory experiments, conducted in vitro, demonstrated promising results. When HGF was incubated with either GSSSG or LASSS, a reduction in nitration was observed at the critical Y198 and Y250 sites on the HGF protein. However, despite this protective effect against nitration, neither compound, at the tested concentrations, was able to fully restore the protein’s diminished ability to bind to its c-MET receptor. This indicated that while the compounds offered some protection against damage, they did not entirely overcome the functional impairment.
To further investigate the potential of these trisulfides, the researchers adjusted the experimental conditions. They systematically increased the molar ratio of HGF to trisulfide, escalating the concentration of the antioxidant compounds from an initial ratio of 1:4000 to a more substantial 1:8000. This adjustment aimed to determine if a higher concentration of the protective agents could elicit a more pronounced effect.
LASSS Emerges as a Potent Enhancer of HGF Signaling
The increased concentration yielded an unexpected and highly significant outcome, particularly with lipoic acid trisulfide (LASSS). When HGF was pre-mixed with LASSS at the higher molar ratio, its capacity to bind to the c-MET receptor not only recovered but surpassed that of untreated, non-nitrated HGF, increasing by more than twofold. Furthermore, the LASSS-treated HGF exhibited enhanced resistance to the functional decline induced by nitration, with a notable protective effect observed particularly at the Y198 site.
Remarkably, this potent enhancement of HGF binding and resistance to nitration was observed exclusively with LASSS. The other trisulfide compound tested, GSSSG, did not elicit the same magnitude of beneficial effect.
"This outcome genuinely exceeded our expectations," Professor Tatsumi commented, expressing his surprise and enthusiasm. "We were aware that trisulfides possess a diverse range of biological functions, but we had not anticipated that the simple act of incubating HGF with LASSS would lead to such a striking improvement in its signaling capabilities.
"What this suggests to us," he continued, "is that LASSS likely operates through mechanisms beyond simply neutralizing reactive molecules. It is plausible that LASSS directly interacts with the HGF protein, inducing a subtle yet crucial conformational change. This alteration could result in the formation of an enhanced ‘Super HGF’ variant, which exhibits a stronger affinity for the c-MET receptor and simultaneously possesses greater resilience against the detrimental effects of nitration."
These findings strongly suggest that LASSS might not merely act as a passive antioxidant but could actively modify the structure of HGF in a manner that is biologically advantageous. Instead of solely acting as a scavenger of damaging molecules, LASSS appears capable of transforming HGF into a more potent and stable signaling agent that binds more effectively to its target receptor and is better equipped to withstand chemical insults.
Promising Efficacy Demonstrated in a Mouse Model
To ascertain whether the observed protective and enhancing effects of LASSS could translate from isolated proteins in a laboratory setting to functional benefits within a living organism, the research team conducted further experiments. They utilized a well-established mouse model of muscle atrophy induced by tail suspension – a condition that simulates the effects of prolonged inactivity and disuse, mirroring some aspects of aging and spaceflight.
Mice that were administered LASSS prior to the tail suspension procedure exhibited significantly lower levels of protein nitration within their skeletal muscle tissue compared to the untreated control group. This in vivo observation corroborated the in vitro findings, demonstrating that LASSS could indeed confer protection against nitration in a complex biological environment. Consistent with the previous experiments, GSSSG failed to provide any measurable protective effect in this animal model.
These results are particularly encouraging as they indicate that the beneficial effects of LASSS are not confined to experiments involving isolated proteins but can extend to tissues within a living system. However, the researchers emphasize that further comprehensive studies are imperative. Specifically, investigations involving aging animals are crucial to thoroughly assess the safety and efficacy of LASSS as a therapeutic intervention in a more directly relevant context.
A Potential Strategy for Preserving Muscle Integrity
The discovery of LASSS’s ability to enhance HGF function holds significant promise for the development of novel therapeutic strategies aimed at preserving muscle repair capabilities. Such interventions could be invaluable for individuals experiencing muscle deterioration due to aging, prolonged periods of bed rest, immobilization following injury or surgery, and other conditions characterized by extended inactivity.
The researchers posit that the beneficial effects of LASSS on HGF signaling might be conserved across a wide range of species, including humans, as well as companion animals such as cats and dogs, which also experience age-related muscle decline. The potential implications are far-reaching: by bolstering the body’s innate muscle repair mechanisms, interventions based on this discovery could contribute to maintaining physical strength, preserving functional independence, enhancing overall quality of life, and potentially extending a healthy lifespan for individuals as they age.
The scientific community will undoubtedly be watching closely as this research progresses. The development of effective countermeasures against age-related muscle loss remains a critical challenge, and the findings from Kyushu University offer a compelling new direction for future research and therapeutic innovation.
